Priming Immunity

for a Healthier Tomorrow

Ultraviolet blood irradiation (UBI) has the potential to turn cold tumors hot, enhance modern immunotherapies, and help prepare for future pandemics.

ACTIVATED IMMUNE CELL

COLD TUMOR (IMMUNE EVASIVE)

From possibility to progress.

Optimizing precise biomolecular targeting using high-energy UV-biotech arrays to elevate therapeutic payloads.

Deploying scalable germicidal modules for rapid, broad-spectrum pathogen neutralization across clinical and public sectors.

Engineered with targeted optical safety calibration to ensure zero side-effects and precise cell-by-cell protection.

Validating next-gen clinical UV innovations in world-class laboratories to deliver immediate, life-changing treatment outcomes.

A simple, device-based process designed to activate the body's natural defenses.

A precise amount of blood is gently withdrawn using clinical access to prepare for therapy.

The blood passes through a precision-controlled UV chamber, exposing it to systemic light frequencies.

Photo-absorption triggers a protective immune response, activating host defense mechanisms.

The oxygenated, energized blood is safely returned, triggering systemic wellness benefits.

The same immune-priming mechanism may address today’s biggest medical challenges.

Targeting solid tumors with programmable immune-priming agents designed to activate the body's natural defenses and turn cold tumors hot.

Engineering rapidly deployable countermeasures and broad-spectrum platforms to neutralize emerging global viral threats.

Learn more about our science, research, and vision.

Advancing immune health for people today — and a healthier tomorrow.